|
Bordetella pertussis
(Whooping Cough)
and other species
Read the Chapter
Sliding Table of
Contents on the left of the screen
Tables and Figures
Table 1: Antimicrobial Susceptibility (µg/ml) of
Bordetella pertussis and B. parapertussis
Table 2: Results from pertussis vaccine efficacy
trials
Vignettes
Cherry JD.
Historical Perspective on Pertussis and Use of Vaccines
To Prevent It. 100 years of pertussis (the cough of 100 days).
Microbe 2007;2:139-144.
Shapiro-Shapin CG.
The Pertussis Vaccine: Triumph of Collaboration in a Small Town in Michigan. Emerg Infect Dis.
2010 Aug;16:1273-78.
Devasia RA, Jones TF,
Compliance with Azithromycin Versus Erythromycin in
the Setting of a Pertussis Outbreak.
Am J Med Sci. 2009 Mar;337:176-8.
Forsyth K.
Pertussis, Still a Formidable Foe. Clin
Infect Dis. 2007 Oct 19;45.
Mooi FR, van Loo IH, et al.
Bordetella pertussis strains with increased toxin
production associated with pertussis resurgence. Emerg Infect Dis.
2009 Aug;15:1206-13.
Review Article:
Adhikari P, Mietzner T. Cell Mediated Immunity. 2008.
Authors
Jussi Mertsola, M.D.,
Qiushui He, M.D.
|
www.antimicrobe.org